值得一提的是，今年10月份，海大集团公告，公司拟将其控股子公司海大控股分拆至中国香港联交所主 板上市。 日前，海大集团发布2025年三季度报告，该公司前三季度营业收入为960.94亿元，同比增长13.24%。归 属于上市公司股东的净利润为41.42亿元，同比增长14.31%。归属于上市公司股东的扣除非经常性损益 的净利润为41.77亿元，同比增长18.71%。基本每股收益为2.49元。 智通财经APP获悉，据报道，海大集团(002311.SZ)选定银行安排香港上市事宜。报道引述匿名消息指， 海大集团正与中金公司、广发证券和摩根大通商议香港上市安排，或最快于明年进行。不过，报道也知 情人士强调，相关讨论仍在进行中，发行规模和时间等细节可能还会有变化。 据悉，海大集团2009年在深圳上市。海大集团网站上的信息显示，该公司成立于1998年，拥有超过4万 名员工，业务涵盖动物营养、动物育种、动保疫苗、智慧养殖、食品加工等现代农牧全产业链。 ...

日前，海大集团发布2025年三季度报告，该公司前三季度营业收入为960.94亿元，同比增长13.24%。归 属于上市公司股东的净利润为41.42亿元，同比增长14.31%。归属于上市公司股东的扣除非经常性损益 的净利润为41.77亿元，同比增长18.71%。基本每股收益为2.49元。 值得一提的是，今年10月份，海大集团公告，公司拟将其控股子公司海大控股分拆至中国香港联交所主 板上市。 据报道，海大集团（002311）(002311.SZ)选定银行安排香港上市事宜。报道引述匿名消息指，海大集 团正与中金公司（601995）、广发证券和摩根大通商议香港上市安排，或最快于明年进行。不过，报道 也知情人士强调，相关讨论仍在进行中，发行规模和时间等细节可能还会有变化。 据悉，海大集团2009年在深圳上市。海大集团网站上的信息显示，该公司成立于1998年，拥有超过4万 名员工，业务涵盖动物营养、动物育种、动保疫苗、智慧养殖、食品加工等现代农牧全产业链。 ...

智通财经APP获悉，据报道，海大集团(002311.SZ)选定银行安排香港上市事宜。报道引述匿名消息指， 海大集团正与中金公司、广发证券和摩根大通商议香港上市安排，或最快于明年进行。不过，报道也知 情人士强调，相关讨论仍在进行中，发行规模和时间等细节可能还会有变化。 日前，海大集团发布2025年三季度报告，该公司前三季度营业收入为960.94亿元，同比增长13.24%。归 属于上市公司股东的净利润为41.42亿元，同比增长14.31%。归属于上市公司股东的扣除非经常性损益 的净利润为41.77亿元，同比增长18.71%。基本每股收益为2.49元。 值得一提的是，今年10月份，海大集团公告，公司拟将其控股子公司海大控股分拆至中国香港联交所主 板上市。 据悉，海大集团2009年在深圳上市。海大集团网站上的信息显示，该公司成立于1998年，拥有超过4万 名员工，业务涵盖动物营养、动物育种、动保疫苗、智慧养殖、食品加工等现代农牧全产业链。 ...

Core Viewpoint - Haida Group announced a share repurchase plan of 1 billion to 1.6 billion CNY to enhance investor confidence and optimize corporate governance after its market value fell below 100 billion CNY [1][4]. Group 1: Share Repurchase Plan - The company plans to repurchase shares using self-raised funds, with a total amount between 1 billion and 1.6 billion CNY, at a price not exceeding 62.00 CNY per share [1][4]. - 1 billion CNY of the repurchased shares will be used for cancellation and reduction of registered capital, while any amount exceeding this will be allocated for employee stock ownership plans [1][4]. - The repurchase period is set for five months following the approval by the shareholders' meeting [4]. Group 2: Financial Metrics - As of September 30, 2025, Haida Group reported total assets of 50.816 billion CNY, current assets of 25.255 billion CNY, and net assets attributable to shareholders of 25.269 billion CNY [4]. - The maximum repurchase amount of 1.6 billion CNY would represent approximately 3.15% of total assets, 6.34% of current assets, and 6.33% of net assets [4]. - The estimated number of shares to be repurchased ranges from approximately 16.13 million shares (0.97% of total shares) at the lower limit to about 25.81 million shares (1.55% of total shares) at the upper limit [4]. Group 3: Recent Stock Performance - Haida Group's stock price has decreased by 12.50% since September 15, significantly outpacing the sector's decline of 7.25% [5]. - As of October 28, the stock closed at 56.69 CNY, down 2.56%, with a total market capitalization of 94.3 billion CNY [1][6]. Group 4: Business Performance - For the first three quarters of 2025, Haida Group achieved revenue of 96.094 billion CNY, a year-on-year increase of 13.24%, and a net profit attributable to shareholders of 4.142 billion CNY, up 14.31% [7]. - The company reported a third-quarter revenue of 37.263 billion CNY, reflecting a 14.43% year-on-year growth [7]. - The overseas market has become a significant growth driver, with revenue from international markets reaching 8.218 billion CNY in the first half of 2025, a 10.87% increase year-on-year [7][8]. Group 5: Strategic Initiatives - Haida Group plans to spin off its subsidiary Haida Holdings for a listing on the Hong Kong Stock Exchange, focusing on feed, seed, and veterinary products in overseas markets [9]. - This strategic move aligns with the national "Belt and Road" initiative and aims to enhance the company's global competitiveness and influence [9].

Core Viewpoint - Haida Group plans to repurchase shares worth between 1 billion to 1.6 billion yuan to enhance investor confidence and optimize corporate governance [1][4]. Group 1: Share Repurchase Plan - The company announced a share repurchase plan on October 28, intending to buy back shares using self-raised funds, with a total amount not less than 1 billion yuan and not exceeding 1.6 billion yuan, at a price not exceeding 62.00 yuan per share [4]. - Of the repurchased shares, 1 billion yuan will be used for cancellation to reduce registered capital, while any amount exceeding this will be allocated for equity incentive plans and/or employee stock ownership plans [1][4]. - The repurchase period is set to be within five months after the shareholders' meeting approval [4]. Group 2: Financial Metrics - As of September 30, 2025, Haida Group reported total assets of 50.816 billion yuan, current assets of 25.255 billion yuan, and net assets attributable to shareholders of 25.269 billion yuan [4]. - If the maximum repurchase amount of 1.6 billion yuan is considered, it would represent approximately 3.15% of total assets, 6.34% of current assets, and 6.33% of net assets [4]. - The estimated number of shares to be repurchased at the maximum amount is at least 25.81 million shares, accounting for 1.55% of the total share capital [4]. Group 3: Recent Stock Performance - Since September 15, Haida Group's stock price has decreased by 12.50%, significantly more than the sector's decline of 7.25% [5]. - The stock closed at 56.69 yuan per share on October 28, down 2.56% [1]. Group 4: Business Performance - For the first three quarters of 2025, Haida Group achieved revenue of 96.094 billion yuan, a year-on-year increase of 13.24%, and a net profit attributable to shareholders of 4.142 billion yuan, up 14.31% [7]. - The overseas market has become a significant growth driver, with revenue from international regions reaching 8.218 billion yuan in the first half of 2025, a year-on-year increase of 10.87%, accounting for 13.97% of total revenue [7][8]. Group 5: Future Plans - Haida Group plans to spin off its subsidiary Haida Holdings for a listing on the Hong Kong Stock Exchange, focusing on feed, seed, and veterinary products in Asia (excluding East Asia), Africa, and Latin America [9]. - This spin-off is part of the company's strategy to enhance its global presence and competitiveness, aligning with national initiatives [9].

Core Viewpoint - The investor relations event held on September 19, 2025, focused on the core businesses of Xianfeng Holdings, particularly in the fields of copper-clad laminates and animal health vaccines, attracting significant market attention [1][2]. Group 1: Copper-Clad Laminate Business - Investors showed particular interest in the performance of the copper-clad laminate business since July, focusing on aspects such as product gross margin, customer resources, cost control, and product qualification rates [3]. - The company reported a gross margin improvement in the first half of the year through customer structure optimization and product structure upgrades, achieving a production value of approximately 350 million [3]. - There was no clear indication from the company regarding the mass production of the high-speed M8 copper-clad laminate or the status of mid-to-high-end customers [3]. - The company has established a joint venture with Jiangxi Hangyu to integrate their copper-clad laminate businesses, leveraging complementary strengths for high-performance production [3]. Group 2: Animal Health Vaccine and Other Business Situations - The animal health vaccine business is currently operating normally, and the company is actively working on market expansion, internal cost control, and quality improvement to enhance operational performance [4]. - The company is monitoring the potential auction of 114.15 million shares held by the controlling shareholder and will fulfill its information disclosure obligations regarding any changes [4]. - Despite reporting a loss in the net profit excluding non-recurring items, the company aims to improve its operational situation by expanding market reach and enhancing cost efficiency across all business areas [4]. - The main business focus remains on copper-clad laminates, which are part of the new productivity electronic information industry [4].

| 3、请祥细介绍公司核心业务覆铜板目前生产经营情况，包括 | | --- | | 但不于公司采取何措施降本增效和提高毛利率等情况，从而增 | | 加投资者投资公司股票信心！ | | 答：您好，目前公司核心业务覆铜板生产经营正常，公司通过 | | 客户结构优化，产品结构升级等方式在上半年实现了一定程度 | | 的毛利率提升，未来将进一步降本增效，整体提升盈利能力， | | 感谢关注。 | | 4、请问贵公司与东莞东城贤丰新能源科技项目有关吗？贵公 | | 司生产经营情况如何？贵公司何时采取符合规定的有效措施 | | 积极改善公司经营状况呢？ | | 答：您好，该项目非上市公司项目，目前公司主营业务为覆铜 | | 板和动保疫苗，经营情况正常开展。公司将积极开拓市场，并 | | 从内部的成本控制，质量提升等方式进一步降本增效来改善经 | | 营状况。感谢您的关注。 | | 5、请问董事长，贤丰控股集团的剩余股份 1.1415 亿股是否将 | | 被拍卖？将会如何处理？ | | 答：您好，公司会对控股股东及其一致行动人的股权变动事宜 | | 保持关注，并按照法律规定及公司章程的规定及时履行信息披 | | 露义务、保 ...